Delivery Order SPE2DB20D2014-SPE2DB25FC69F
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,033.20 to AmerisourceBergen Drug Corp for Refresh Tears 0.5% eye drop solution (15ml) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office location in...
- The Defense Logistics Agency has awarded a delivery order valued at $1,064.05 to AmerisourceBergen Drug Corp for Refresh Tears 0.5% eye drops (15 mL). This firm fixed-price, non-set-aside contract was awarded on May 30, 2025, with an ultimate completion date of June 2, 2025. Performance will be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,381.67 to AmerisourceBergen Drug Corp for Refresh Tears 0.5% eye drop solution (15 mL) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction executed under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Refresh Tears 0.5% eye drops in 15ml quantities, with a contract ceiling value of $1,280.72. This is a firm fixed-price delivery order under a non-set-aside competitive award, with an ultimate completion date of November 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,142.15 delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for Refresh Tears 0.5% eye drop solution in 15ml quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 15, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Refresh Tears 0.5% eye drops in 15ml quantities, with a ceiling value of $1,180.80. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The award carries no set-aside designation, indicating it was competitively awarded. Performance...
- The Defense Logistics Agency awarded a $2,474.50 delivery order to AmerisourceBergen Drug Corp for Refresh Tears 0.5% eye drops (15mL) on May 20, 2025, with an ultimate completion date of May 21, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Tears 0.5% eye drops (15 mL) with a ceiling value of $1,277.84 under a firm fixed-price contract structure. This is a non-set-aside award issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under the company's...
- This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen) is a $2,345.55 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) for the supply of 0.5% Refresh Tears eye drops in 15ml bottles. The contract has a period of performance through June 14, 2024 and was awarded on June 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,293.36, is a Delivery Order for the supply of REFRESH TEARS 0.5% EYE DROP 15ML. The contract has a firm fixed price pricing type and an ultimate completion date of December 19, 2024. There was no set-aside designation used for this award. AmerisourceBergen holds a significant Indefinite...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC69FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,875.35 to AmerisourceBergen Drug Corp for Refresh Tears 0.5% Eye Drop (15ml) on August 7, 2025, with completion scheduled for August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug Corp's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen leverages this contract to supply a broad portfolio of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company's consistent performance on DLA contracts reflects its capability to meet federal procurement requirements across diverse therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/7/25 |